Yahoo Finance's Julia La Roche sits down with executive chairman and former CEO of Starbucks Howard Schultz
|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||22.30 - 22.32|
|52 Week Range||18.25 - 22.39|
|PE Ratio (TTM)||262.59|
|Expense Ratio (net)||0.30%|
In 1H17, Novartis’s (NVS) Lucentis reported revenues of around $922 million, which is a ~1% decline on a year-over-year (or YoY) basis.
In 1H17, Teva Pharmaceutical's (TEVA) respiratory franchise reported revenues of ~$626 million, or ~8% lower YoY (year-over-year).
At constant exchange rates, AstraZeneca reported an 8% decline in its product sales of ~$4.9 billion during 2Q17.